Aspira Women’s Health stockholders approve all proposals at 2024 annual meeting

Aspira Women's Health Inc.

Elected six directors (Stefanie Cavanaugh, Celeste R. Fralick, Jannie Herchuk, Lynn O’Connor Vos, Nicole Sandford, Winfred Parnell) with >4.1M votes for each.
Advisory say-on-pay approved: 4,189,574 for, 97,653 against, 1,752 abstain.
Amended 2019 Stock Incentive Plan to increase authorized shares by 1,000,000 (total ISOs up to 3,000,000): 4,187,597 for, 98,942 against.
Ratified BDO P.C. as auditor for FY2024: 7,992,912 for, 88,066 against, 12,358 abstain.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Aspira Women's Health Inc. shareholders approved Ratification of the Selection of the Company’s Independent Registered Public Accounting Firm at the 2024-05-13 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2024-05-13

Exact text from the filing

000 shares and increase the maximum number of awards that may be granted as incentive stock options under the 2019 Plan to a total of 3,000,000 shares, as set forth below: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 4,187,597 98,942 2,440 3,804,357 Proposal 4: Ratification of the Selection of the Company’s Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection of BDO USA, LLP (n/k/a BDO P.C.) as the Company’s independent registered public accounting firm for the year ending December 31, 2024, as set forth below: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 7,992,912 88,066 12,358

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Aspira Women's Health Inc. shareholders approved Election of Directors at the 2024-05-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2024-05-13

Exact text from the filing

NOMINEE FOR AGAINST ABSTENTIONS BROKER NON-VOTES Stefanie Cavanaugh 4,213,732 69,683 5,564 3,804,357

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Aspira Women's Health Inc. shareholders approved Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers at the 2024-05-13 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2024-05-13

Exact text from the filing

4,214,222 73,859 898 3,804,357 Proposal 2: Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 1, 2024, as set forth below: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 4,189,574 97,653 1,752 3,804,357 Proposal 3: Approval of an Amendment to the Aspira Women’s Health Inc.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Aspira Women's Health Inc. shareholders approved Approval of an Amendment to the Aspira Women’s Health Inc. 2019 Stock Incentive Plan at the 2024-05-13 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2024-05-13

Exact text from the filing

y’s named executive officers as disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 1, 2024, as set forth below: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 4,189,574 97,653 1,752 3,804,357 Proposal 3: Approval of an Amendment to the Aspira Women’s Health Inc. 2019 Stock Incentive Plan The Company’s stockholders approved an amendment to the Company’s 2019 Stock Incentive Plan (the “2019 Plan”) to increase the number of shares of common stock authorized to be granted under the 2019 Plan by 1,000,000 shares and increase the maximum number of awards that may be granted as incentive stock options under the 2019 Plan to a total of 3,000,000 shares, as set forth below: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 4,187,597 98,942 2,440 3,804,357 Proposal 4: Ratification of the Selection of the Company’s Independent Registered Public Accou

View on SEC.gov

139 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-059543

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.